Hippocampal atrophy rates and CSF biomarkers in elderly <i>APOE</i> 2 normal subjects

Abstract

A slower rate of hippocampal atrophy in normal APOE2 carriers is consistent with the lower risk of Alzheimer disease in these individuals. We hypothesize that the slower atrophy rate is related to decreased preclinical Alzheimer pathology.